echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > JAMA Sub-Journal: Elderly people may overuse aspirin, especially diabetic patients

    JAMA Sub-Journal: Elderly people may overuse aspirin, especially diabetic patients

    • Last Update: 2021-07-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Aspirin, as one of the three classic drugs in the history of medicine, has a history of hundreds of years since its clinical application, and is still a good medicine for antipyretic, analgesic and anti-inflammatory drugs
    .


    With the development of medicine, many studies have found that aspirin can reduceHeart blood vessels occurrence of an event, for ages 50--59 years old at high risk for cardiovascular disease, guidelines have been used as a cardiovascular disease prevention


    Aspirin, as one of the three classic drugs in the history of medicine, has a history of hundreds of years since its clinical application, and is still a good medicine for antipyretic, analgesic and anti-inflammatory drugs


    pixabay

    pixabay

    Studies have shown that diabetic patients suffering from CVD risk in patients with non-diabetic 2 Dao 4 times, but the role of aspirin in primary prevention in people with diabetes is unclear
    .


    Recently, a study published in the journal JAMA Netw Open explored the use of aspirin in elderly people with and without diabetes in the United States


    Studies have shown that diabetic patients suffering from diabetic patients suffering from diabetes, CVD risk of non-diabetic patients with 2 Dao 4 CVD risk in patients with non-diabetic 2 Dao 4 times, but the role of aspirin in primary prevention in people with diabetes is unclear


    The study used nationally representative data from the National Health and Nutrition Examination Survey from2011 to 2018 .
    A total of 7103 Ming 60 years or older diabetics and non-diabetic patients completed a questionnaire on prophylactic aspirin use .
    The use of prophylactic aspirin was defined as the use of low-dose aspirin by participants based on doctor’s recommendation or self-decision .
    Statistical analysis time is 2019 Nian 7 Yue 1 to 2021 Nian 4 Yue 1 Ri .

    The results of the study showed that a total of 7103 participants 60 years of age or older were included , of which 45.


    2% were men and 75.
    8% were white


    The results of the study showed that a total of 7103 participants 60 years of age or older were included , of which 45.
    2% were men and 75.


    Among people who do not have cardiovascular disease but have diabetes, those who take aspirin are also more likely to be men.
    Those who take aspirin are also more likely to be men , and the average waist circumference (mean [SD] , 110.


    Aspirin use in different age groups and cardiovascular disease (CVD) status among elderly people with and without diabetes

    Aspirin use in different age groups and cardiovascular disease (CVD) status among elderly people with and without diabetes

    Among people without cardiovascular disease and diabetes, the average age of aspirin users is higher (using aspirin, 70.


    2[0.


    In people without cardiovascular disease and diabetes, the average age of aspirin users is higher (using aspirin, and in people without cardiovascular disease and diabetes, the average age of aspirin users is 70.


    Association of age, gender and cardiovascular disease with aspirin for primary or secondary prevention

    Association of age, gender and cardiovascular disease with aspirin for primary or secondary prevention

    In the logistic regression model, after adjusting for age, race / ethnicity, gender, education, CVD risk, and BMI , diabetes was significantly associated with a significantly higher chance of using aspirin
    .


    Among people with diabetes, there is no difference in the likelihood of using aspirin for primary or secondary prevention between high-risk and low-risk groups


    In the logistic regression model, after adjusting for age, race / ethnicity, gender, education, CVD risk, and BMI , diabetes was significantly associated with a significantly higher chance of using aspirin


    In summary, the possibility of the United States, the use of aspirin in patients with diabetes than non-primary prevention of diabetes high in the United States, the possibility of using aspirin for diabetics than non-primary prevention of diabetes 1 times
    .
    Women are significantly less likely to use aspirin than men, especially in diabetic patients
    .
    In people without diabetes, the older the age, the more likely it is to use aspirin
    .
    It is even more necessary for healthcare providers to ask their elderly patients about the use of aspirin, and in view of recent changes in the guidelines, discuss the risks and benefits of continuing aspirin therapy to prevent cardiovascular disease
    .
    1 times
    .
    Women are significantly less likely to use aspirin than men, especially in diabetic patients
    .
    In people without diabetes, the older the age, the more likely it is to use aspirin
    .
    It is even more necessary for healthcare providers to ask their elderly patients about the use of aspirin, and in view of recent changes in the guidelines, discuss the risks and benefits of continuing aspirin therapy to prevent cardiovascular disease
    .

    Original source

    Original source

    Elizabeth Y.
    Liu, BA1;  Mohammed E.
    Al-Sofiani, MBBS, MSc1,2 ;  Hsin-Chieh Yeh, PhD3,4,5 ; et al.
    Use of Preventive Aspirin Among Older US Adults With and Without Diabetes .
    JAMA Netw Open .
    2021;4(6):e2112210.
    doi:10.
    1001/jamanetworkopen.
    2021.
    12210

    Elizabeth Y.
    Liu, BA1;  Mohammed E.
    Al-Sofiani, MBBS, MSc1,2 ;  Hsin-Chieh Yeh, PhD3,4,5 ; et al.
    Use of Preventive Aspirin Among Older US Adults With and Without Diabetes .
    JAMA Netw Open .
    2021;4(6):e2112210.
    doi:10.
    1001/jamanetworkopen.
    2021.
    12210 Mohammed E.
    Al-Sofiani, MBBS, MSc1,2 Hsin-Chieh Yeh, PhD3,4,5 Use of Preventive Aspirin Among Older US Adults With and Without Diabetes leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.